World Drug Report

Availability of science-based treatment improving, says 2021 World Drug Report

Around 275 million people used drugs worldwide in the last year, while over 36 million people suffered from drug use disorders, according to the 2021 World Drug Report, released today by the United Nations Office on Drugs and Crime (UNODC).

World Drug Report 2022

Published by
Publication Date
The 2022 World Drug Report provides a global overview of the supply and demand of opiates, cocaine, cannabis, amphetamine-type stimulants and new psychoactive substances (NPS), as well as their impact on health.

Highlights from the 2022 UNODC World Drug Report: Implications for drug prevention, treatment and care responses

Vienna, Austria,

ISSUP presented a webinar on Thursday, July 7, 2014, featuring Giovanna Campello, Chief of the Prevention, Treatment and Rehabilitation Section, United Nations Office on Drugs and Crime (UNODC) presenting highlights from the 2022 edition of the UNODC World Drug Report. The presentation included implications on drug prevention, treatment and rehabilitation responses during times of crisis.

Time: 2PM UK | 3PM Vienna

Webinar for Civil Society: The World Drug Report 2022


Learn more about the newest trends regarding the World Drug Situation in this webinar for civi society. UNODC experts will present this year's World Drug Report 2022, giving an overview about the latest developments and diving into the newest available global data.

In the second part two civil society representatives will explain how they use the World Drug Report in their day-to-day work.

Launch of the 2022 World Drug Report

Online, Austria,

The World Drug Report 2022 presents an overview of the current trends on global drug markets and includes the latest information on drug use, production, and trafficking. It analyzes the gender gap relating to drug use and the impact of the COVID-19 pandemic.

World Drug Report 2021

Published by
Publication Date
Consisting of five separate booklets, the World Drug Report 2021 provides an in-depth analysis of the global drug markets and paints a comprehensive picture of the measurable effects and potential impact of the COVID-19 crisis on the world drug problem.